Startup’s ‘escape artist’ approach could h
Author: Michael
NeuroSense announced that its Phase 2b PARADIGM s
Insilico Medicine has promoted its Pharma.
United Therapeutics announced that the U.S.
4DMT has completed global enrollment for 4FRONT-2
Boston biotech secures Series A funding to move
Former Verge Genomics is building AI models from
15,000-woman waitlist suggests demand for precis
FDA Breakthrough Therapy Designation for fosigot
New evidence suggests one overlooked saturated f